We enable severe headache sufferers to benefit from unique neurostimulation and image guided therapeutic solutions by turning innovative ideas into reality.

Our therapies are allowing headache patients to return to a normal, pain free life. 

We enable severe headache sufferers to benefit from unique neurostimulation and image guided therapeutic solutions by turning innovative ideas into reality.

Our therapies are allowing headache patients to return to a normal, pain free life. 

Headache is a severe disabling disorder

Chronic migraine

Migraine is amongst the most common neurological disorders globally, affecting 1 in 5 women and 1 in 15 men.

Characterised by a severe throbbing head pain, migraine headache is often accompanied by additional neurological symptoms including nausea & vomiting.

Migraine attacks can last more than a day and in chronic migraine, sufferers experience debilitating migraine attacks on more than 15 days per month.

Consequently, when a migraine attack occurs, it has a severe impact on all aspects of life.

Cluster headache

Cluster headache has been described as one of the most painful conditions known to mankind.

Often described as ‘Suicide Headache’, cluster headache is characterised by excruciating one sided head pain typically felt behind the eye, around the temple & face. These attacks typically last from 15 minutes to a few hours and can occur up to 8 times per day. Cluster headaches typically occur in bouts lasting 4 to 12 weeks, but patients who suffer with chronic cluster headache experience attacks almost every day with no break.

neuromodulation for headache

Neurostimulation

Delivery of electrical current to the occipital nerves located at the back of the head has been shown to improve the severity and frequency of headache attacks. We are developing a novel, minimally invasive, battery free neurostimulation system to reduce the pain and frequency of severe headache attacks, that can be inserted in as little as 20 minutes.

Image Guided Therapies

Using our image guided navigation technology, we are able to deliver therapies with millimeter precision directly to nerve bundles involved in severe headache, interrupting the nerve signals to reduce the pain and frequency of attacks. Our innovative technology enables patients to benefit from a precision targeted injection in an outpatient environment in a short, awake, 15 minute procedure.

We are hiring!

Man & Science team consists of experienced scientists, engineers, and successful start-up founders and entrepreneurs. We are actively looking for highly talented and motivated people to join our R&D team. If you are starting your career or have a strong experience in active neurostimulation implants, and you are interested in working in a dynamic and motivated team, we are looking forward to receive your CV and application at jobs@mananscience.com

Send an e-mail

We are hiring!

Man & Science team consists of experienced scientists, engineers, clinical research specialists, business experts and successful start-up founders and entrepreneurs.

We are actively looking for highly talented and motivated people to join our R&D, Clinical & QA teams. If you are just starting out in your career or experienced in neuromodulation therapies, and are interested in working in a dynamic and motivated team, we look forward to receiving your CV and application at jobs@manandscience.com.

Management team

Robert Taub, Chief Executive Officer

Christelle Nguepi, Director of Clinical & Regulatory Affairs

David Barnes, Director of Marketing & Commercialization

Bert Bakker, CTO - Chief Technical Officer

Caroline Smal, Director of QA & Compliance

Fausto Remedia, Finance & Administration Manager

Norman Plassky, VP Image Guided Therapies

Prof. Daniel Bratbak, CSO

Christelle Nguepi, Project Manager

Véronique Peeters, Finance Manager

Board of directors

Robert Taub, Chairman

Dr. Jürgen Hambrecht, Board member

Hugues WALLEMACQ, Board Member

Anneliese Monden, Board member

Olivier Taeleman, Board member

Scientific advisory board

Prof. Jean-Pierre Van Buyten, MD, PhD, Principal scientist

Prof. Koen Paemeleire, MD, PhD

Prof. Jean Schoenen, MD, PhD

Prof. Erling Tronvik, MD, PhD

Read our latest news

Contact us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.